Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about GSK plc
Recent news which mentions GSK plc
< Previous
1
2
Next >
Pfizer RSV vaccine maintains protection in older adults over two seasons in trial
February 29, 2024
Tags
GSK plc
Health & Science
Pharmaceuticals
From
CNBC.com News
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
February 27, 2024
Tags
Sanofi SA
Europe Economy
Breaking News: Investing
From
CNBC.com News
Cramer's Lightning Round: 'Hold off' on Kroger
February 05, 2024
Tags
stocks
Business
Markets
From
CNBC.com News
GSK posts blowout RSV vaccine sales, raises outlook as shots give big pharma a boost
January 31, 2024
Tags
Business
Biotech and Pharmaceuticals
Moderna Inc
From
CNBC.com News
5 things to know before the stock market opens Monday
January 29, 2024
Tags
Investment strategy
Advanced Micro Devices Inc
United Parcel Service Inc
From
CNBC.com News
Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth
January 14, 2024
Tags
Business News
Breaking news
Pharmaceuticals
From
CNBC.com News
RSV vaccine from GSK shows potential to protect adults 50 to 59
October 25, 2023
Tags
Immunizations
Respiratory syncytial virus
Health & Science
From
CNBC.com News
Moderna combination Covid, flu vaccine moves to final stage trial after positive data
October 04, 2023
Tags
Biotech and Pharmaceuticals
Moderna Inc
Science
From
CNBC.com News
Covid, RSV and flu vaccines are now available — here's how to decide whether to get them together
September 15, 2023
Tags
COVID/19
Health care industry
Biotechnology
From
CNBC.com News
Moderna says flu vaccine showed promising results in phase three trial, paving path to approval
September 13, 2023
Tags
Flu
US: News
Biotechnology
From
CNBC.com News
Covid vaccine rollout begins early in the UK with new variant under watch
September 11, 2023
Tags
Pharmaceuticals
Pfizer Inc
Europe Markets
From
CNBC.com News
These 10 medications are likely targets for Medicare price negotiations this fall
August 10, 2023
Tags
Business
Policy
Bristol/Myers Squibb Co
From
CNBC.com News
GSK sues Pfizer in U.S. court for patent infringement over RSV vaccine
August 02, 2023
Tags
Lawsuits
Respiratory syncytial virus
GSK plc
From
CNBC.com News
GSK chief says RSV vaccine will start off slower than shingles shot – but will drive future sales
July 26, 2023
Tags
Biotech and Pharmaceuticals
Business
Vaccinations
From
CNBC.com News
CDC recommends RSV vaccines from Pfizer, GSK for adults 60 and older
June 29, 2023
Tags
US: News
Pfizer Inc
Health care industry
From
CNBC.com News
Stocks making the biggest moves midday: Starbucks, CarMax, Virgin Galactic and more
June 23, 2023
Tags
stocks
C3 ai Inc
Business
From
CNBC.com News
Pfizer, GSK RSV shots for older adults may prevent thousands of hospitalizations, CDC analysis says
June 22, 2023
Tags
Health & Science
Social issues
GSK plc
From
CNBC.com News
CDC advisory panel backs use of GSK and Pfizer RSV vaccines in adults over 60
June 21, 2023
Tags
US: News
Pfizer Inc
Health care industry
From
CNBC.com News
Stocks making the biggest moves midday: Dollar Tree, Amazon, FedEx and more
June 21, 2023
Tags
Economy
Earnings
Tesla Inc
From
CNBC.com News
GSK says RSV vaccine for older adults provides protection over two seasons
June 21, 2023
Tags
Companies
Biotechnology
Health care industry
From
CNBC.com News
Pfizer RSV vaccine for older adults is only slightly less effective after 18 months
June 21, 2023
Tags
Immunizations
Respiratory syncytial virus
Health & Science
From
CNBC.com News
FDA approves Pfizer RSV vaccine for older adults
May 31, 2023
Tags
Business
Policy
Epidemics
From
CNBC.com News
FDA advisors recommend Pfizer’s RSV vaccine for infants but raise safety concerns
May 18, 2023
Tags
Health care industry
Biotechnology
Companies
From
CNBC.com News
Pfizer RSV vaccine for infants has 'generally favorable' safety data, FDA staff say
May 16, 2023
Tags
Business News
Pharmaceuticals
Health & Science
From
CNBC.com News
Cramer's Lightning Round:
May 15, 2023
Tags
Chewy Inc
Magellan Midstream Partners LP
Amgen Inc
From
CNBC.com News
FDA approves GSK's RSV vaccine for older adults, world's first shot against virus
May 03, 2023
Tags
Respiratory syncytial virus
Immunizations
Regulations
From
CNBC.com News
The EU outlined its plan to equalize drug access and lower prices. Pharma firms are not happy
April 27, 2023
Tags
Biotech and Pharmaceuticals
Europe News
Bayer AG
From
CNBC.com News
Stocks making the biggest moves midday: Southwest Airlines, Goldman Sachs, Bellus Health and more
April 18, 2023
Tags
Johnson & Johnson
Bank of America Corp
Bank of New York Mellon Corp
From
CNBC.com News
J&J backs out of RSV vaccine race with rivals Pfizer and GSK
March 29, 2023
Tags
US: News
Pfizer Inc
Health care industry
From
CNBC.com News
FDA says Guillain-Barre syndrome is possible risk of Pfizer's RSV vaccine for older adults
February 24, 2023
Tags
Breaking News: Business
Disease outbreaks
Pandemics
From
CNBC.com News
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.